Editas Medicine
EDIT
$5.28
Share price
1.34%
Change (1 day)
-36.39%
Change (1 year)
Editas Medicine (EDIT) - P/B ratio
P/B ratio as of May 2024 : 1.23
According to Editas Medicine
's latest financial reports the company has a price-to-book ratio of 1.23.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Editas Medicine - P/B ratio (from 2016 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 2.37 | 40.15% |
| 2022-12-31 | 1.69 | -48.44% |
| 2021-12-31 | 3.28 | -70.46% |
| 2020-12-31 | 11.1 | 81.05% |
| 2019-12-31 | 6.13 | 30.57% |
| 2018-12-31 | 4.70 | -24.49% |
| 2017-12-31 | 6.22 | 40.74% |
| 2016-12-31 | 4.42 | |
| 2015-12-31 | N/A | |
| 2014-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | 1.97 | 60.65% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | 4.74 | 285.90% | 🇬🇧 UK |
 Novavax NVAX | -0.8453 | -168.87% | 🇺🇸 USA |
 Novocure
NVCR | 3.63 | 196.05% | Jersey |